Cite
P2.04-24 Transcriptional Profiling of Neoantigen Specific T Cells in Resectable NSCLC Treated with Neoadjuvant Anti-PD-1
MLA
Julie R. Brahmer, et al. “P2.04-24 Transcriptional Profiling of Neoantigen Specific T Cells in Resectable NSCLC Treated with Neoadjuvant Anti-PD-1.” Journal of Thoracic Oncology, vol. 14, Oct. 2019, p. S717. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........4bffb746fe7994c52c8ba1dc3dfd19f6&authtype=sso&custid=ns315887.
APA
Julie R. Brahmer, Srinivasan Yegnasubramanian, Janis M. Taube, Tricia R. Cottrell, Jarushka Naidoo, Hok Yee Chan, Zhicheng Ji, Justina X. Caushi, Patrick M. Forde, Edward Gabrielson, Taha Merghoub, Kellie N. Smith, M. El Asmar, Kristen A. Marrone, Jamie E. Chaft, Haidan Guo, J. Zhang, Matthew D. Hellmann, Ni Zhao, … Jedd D. Wolchok. (2019). P2.04-24 Transcriptional Profiling of Neoantigen Specific T Cells in Resectable NSCLC Treated with Neoadjuvant Anti-PD-1. Journal of Thoracic Oncology, 14, S717.
Chicago
Julie R. Brahmer, Srinivasan Yegnasubramanian, Janis M. Taube, Tricia R. Cottrell, Jarushka Naidoo, Hok Yee Chan, Zhicheng Ji, et al. 2019. “P2.04-24 Transcriptional Profiling of Neoantigen Specific T Cells in Resectable NSCLC Treated with Neoadjuvant Anti-PD-1.” Journal of Thoracic Oncology 14 (October): S717. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........4bffb746fe7994c52c8ba1dc3dfd19f6&authtype=sso&custid=ns315887.